Overcoming immunotherapy resistance in gastric cancer: insights into mechanisms and emerging strategies
Abstract Gastric cancer (GC) remains a leading cause of cancer-related mortality worldwide, with limited treatment options in advanced stages. Immunotherapy, particularly immune checkpoint inhibitors (ICIs) targeting PD1/PD-L1, has emerged as a promising therapeutic approach. However, a significant...
Saved in:
| Main Authors: | Dingtian Luo, Jing Zhou, Shuiliang Ruan, Binzhong Zhang, Huali Zhu, Yangming Que, Shijie Ying, Xiaowen Li, Yuanmin Hu, Zhengwei Song |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-02-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07385-7 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Overcoming immunotherapy resistance in glioblastoma: challenges and emerging strategies
by: Maowu Fu, et al.
Published: (2025-03-01) -
Understanding and overcoming resistance to immunotherapy in genitourinary cancers
by: Sean T Evans, et al.
Published: (2024-12-01) -
Emerging strategies to overcome ovarian cancer: advances in immunotherapy
by: Tatiana Massariol Pimenta, et al.
Published: (2024-11-01) -
Resistance in Lung Cancer Immunotherapy and How to Overcome It: Insights from the Genetics Perspective and Combination Therapies Approach
by: Paweł Zieliński, et al.
Published: (2025-04-01) -
Advances in immunotherapy for uveal melanoma: enhancing efficacy and overcoming resistance
by: Jian Song, et al.
Published: (2025-06-01)